Risk stratification, perioperative and periprocedural management of the patient receiving anticoagulant therapy
详细信息 查看全文
- 作者：Adriana D. Oprea ; MD ; adriana.oprea@yale.edu" class="auth_mail" title="E-mail the corresponding author (Assistant Professor of Anesthesiology) ; Christopher J. Noto ; MD (Assistant Professor of Anesthesiology) ; Thomas M. Halaszynski ; DMD ; MD ; MBA (Associate Professor of Anesthesiology)
- 关键词：Anticoagulation ; Bridging therapy ; Perioperative period
- 刊名：Journal of Clinical Anesthesia
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：34
- 期：Complete
- 页码：586-599
- 全文大小：340 K
文摘
- •
Perioperative management of anticoagulants has become routine for anesthesiologists.
- •
10">Bleeding and thrombotic risks should be balanced when deciding upon management.
- •
15">Warfarin is usually stopped 5-7 days prior for procedures with high bleeding risk.
- •
Bridging should be considered for patients on warfarin at high thrombotic risk.
- •
Novel anticoagulants can be stopped close to the procedure usually without bridging.